Molecular cloning and expression of a rat Via arginine vasopressin receptor
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The neurohypophyseal hormone arginine vasopressin has diverse actions, including the inhibition of diuresis, contraction of smooth muscle, stimulation of liver glycogenolysis and modulation of adrenocorticotropic hormone release from the pituitary. Arginine vasopressin receptors are G protein-coupled and have been divided into at least three types; the V1a (vascular/hepatic) and V1b (anterior pituitary) receptors which act through phosphatidylinositol hydrolysis to mobilize intracellular Ca2+, and the V2 (kidney) receptor which is coupled to adenylate cyclase. We report here the cloning of a complementary DNA encoding the hepatic V1a arginine vasopressin receptor. The liver cDNA encodes a protein with seven putative transmembrane domains, which binds arginine vasopressin and related compounds with affinities similar to the native rat V1a receptor. The messenger RNA corresponding to the cDNA is distributed in rat tissues known to contain V1a receptors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One is impaired intracellular glucose metabolism due to increased gluconeogenesis and/or increased glycogenolysis as suggested by acute experiments [31,32], an effect probably related to V1aR activation [29].”
From Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats (2015) · cites this paper as [29]
Citations
Cites
High-efficiency transformation of mammalian cells by plasmid DNA.
Chen, C., & Okayama, H. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2745 · Cited by 5,373
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Self-citationCompilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs
Kozak, M. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.2.857 · Cited by 3,293
Cloning and expression of a cDNA encoding an endothelin receptor
Arai, H., Hori, S., Aramori, I., Ohkubo, H., & Nakanishi, S. (1990) · Nature · doi:10.1038/348730a0 · Cited by 2,578
Cloning and expression of a rat D2 dopamine receptor cDNA
Bunzow, J. R., Tol, H. H. M. V., Grandy, D. K., Albert, P., Salon, J., Christie, M., Machida, C. A., Neve, K. A., & Civelli, O. (1988) · Nature · doi:10.1038/336783a0 · Cited by 1,117
Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin
Gillies, G. E., Linton, E. A., & Lowry, P. J. (1982) · Nature · doi:10.1038/299355a0 · Cited by 965
Repetitive transient rises in cytoplasmic free calcium in hormone-stimulated hepatocytes
Woods, N. M., Cuthbertson, K. S. R., & Cobbold, P. H. (1986) · Nature · doi:10.1038/319600a0 · Cited by 793
Cloning and expression of cDNA for a human thromboxane A2 receptor
Hirata, M., Hayashi, Y., Ushikubi, F., Yokota, Y., Kageyama, R., Nakanishi, S., & Narumiya, S. (1991) · Nature · doi:10.1038/349617a0 · Cited by 684
Structure and expression of a human oxytocin receptor
Kimura, T., Tanizawa, O., Mori, K., Brownstein, M. J., & Okayama, H. (1992) · Nature · doi:10.1038/356526a0 · Cited by 632
Self-citationKobilka, B. K., Frielle, T., Collins, S., Yang-Feng, T., Kobilka, T. S., Francke, U., Lefkowitz, R. J., & Caron, M. G. (1987) · Nature · doi:10.1038/329075a0 · Cited by 515
Research works printed but not linked: 5
- Matsuguchi, H., Schmid, P. G., Gorden, F. J. & Johnson, A. K. Physiologist 23, 29–33 (1980).
- Clements, J. A. & Funder, J. W. Endocr. Rev. 116, 416–423 (1986).
- Butlen, D. et al. Molec. Pharmac. 14, 1006–1017 (1978).
- Kozak, M. Nucleic Acids Res. 12, 857–872 (1984). · DOI · Paper page
- Bunzow, J. R. et al. Nature 336, 783–787 (1988). · DOI · Paper page
Cited by
Items 201–300 of 482
Molecular cloning and expression of rat V1a and V2 arginine vasopressin receptors
Morel, A., Lolait, S. J., & Brownstein, M. (1993) · Regulatory Peptides · doi:10.1016/0167-0115(93)90182-8 · Cited by 35
Self-citationMohr, E., Meyerhof, W., & Richter, D. (1995) · Vitamins and hormones · doi:10.1016/s0083-6729(08)61040-7 · Cited by 38
HOWL, J., & WHEATLEY, M. (1996) · Biochemical Journal · doi:10.1042/bj3170577 · Cited by 34
Schmidt, C. G., Höcherl, K., Kurt, B., & Bucher, M. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e318180b51d · Cited by 33
Croiset, G., & de Wied, D. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00070-x · Cited by 33
Andrés, M., Trueba, M., & Guillon, G. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704634 · Cited by 34
The V2 vasopressin receptor mutations and fluid homeostasis
Birnbaumer, M. E. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00337-6 · Cited by 32
The Property of a Novel V2 Receptor Mutant in a Patient with Nephrogenic Diabetes Insipidus
Inaba, S., Hatakeyama, H., Taniguchi, N., & Miyamori, I. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.381 · Cited by 32
Mouillac, B., Manning, M., & Durroux, T. (2008) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955708785740607 · Cited by 35
Arginine Vasotocin: Site and Mode of Action in the Reptilian Kidney
Bradshaw, D., & Bradshaw, F. J. (2002) · General and Comparative Endocrinology · doi:10.1006/gcen.2002.7780 · Cited by 32
Arginine Vasopressin Increases Nitric Oxide Synthesis in Cytokine-Stimulated Rat Cardiac Myocytes
Yamamoto, K., Ikeda, U., Okada, K., Saito, T., Kawahara, Y., Okuda, M., Yokoyama, M., & Shimada, K. (1997) · Hypertension · doi:10.1161/01.hyp.30.5.1112 · Cited by 32
Akhundova, A., Getmanova, E. V., Gorbulev, V., Carnazzi, E., Eggena, P., & Fahrenholz, F. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0759p.x · Cited by 35
Pathogenesis of Sodium and Water Retention in Cardiac Failure
Schrier, R. W., & Fassett, R. G. (1998) · Renal Failure · doi:10.3109/08860229809045175 · Cited by 32
Cheng, L. L., Stoev, S., Manning, M., Derick, S., Pena, A., Mimoun, M. B., & Guillon, G. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030611c · Cited by 32
Ginès, P., Li, X., Zamarripa, J., Brown, S. E., Wieder, E., Nakamura, T., Guzelian, P. S., Schrier, R. W., Heasley, L. E., & Nemenoff, R. A. (1995) · Hepatology · doi:10.1002/hep.1840220440 · Cited by 32
Hormonal Regulation of Nuclear Permeability
O’Brien, E., Gomes, D. A., Sehgal, S., & Nathanson, M. H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606300200 · Cited by 32
Cottet‐Maire, F., Avdonin, P. V., Roulet, E., Buetler, T. M., Mermod, N., & Rüegg, U. T. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703878 · Cited by 31
Vasopressin-induction of cyclic AMP in cultured hippocampal neurons
Brinton, R. D., & Brownson, E. A. (1993) · Developmental Brain Research · doi:10.1016/0165-3806(93)90110-v · Cited by 34
Roles of arginine vasotocin receptors in the brain and pituitary of submammalian vertebrates
(2013) · International Review of Cell and Molecular Biology · doi:10.1016/b978-0-12-407696-9.00004-x · Cited by 30
“The AVP V1a receptor is mainly expressed in vascular smooth muscle cells, in hepatocytes, and in the CNS (Morel et al., 1992; Ostrowski et al., 1994), while the V1b receptor is exclusively located in the corticotrophs of the anterior pituitary (de Keyzer et al., 1994; Sugimoto et al., 1994).”
BackgroundInfluentialŚlusarz, M. J., Sikorska, E., Ślusarz, R., & Ciarkowski, J. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051075m · Cited by 32
Evidence that atypical vasopressin V2 receptor in inner medulla of kidney is V1B receptor
Saito, M., Tahara, A., Sugimoto, T., Abe, K., & Furuichi, K. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00465-9 · Cited by 30
Homologous and Heterologous Phosphorylation of the Vasopressin V1a Receptor
Ancellin, N., Preisser, L., Maout, S. L., Barbado, M., Créminon, C., Corman, B., & Morel, A. (1999) · Cellular Signalling · doi:10.1016/s0898-6568(99)00035-2 · Cited by 30
Self-citationAVP inhibits EGF-stimulated MAP kinase cascade in Madin-Darby canine kidney cells
Yamada, T., Terada, Y., Homma, M. K., Nonoguchi, H., Sasaki, S., Yuasa, Y., Tomita, K., & Marumo, F. (1995) · Kidney International · doi:10.1038/ki.1995.346 · Cited by 30
Wu, C., Lv, C., Wan, Y., Li, X., Zhang, J., Li, J., & Wang, Y. (2019) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2019.05.013 · Cited by 31
Molecular Endocrinology of the Oxytocin Receptor.
Kimura, T., & Saji, F. (1995) · Endocrine Journal · doi:10.1507/endocrj.42.607 · Cited by 30
Yazawa, H., Hirasawa, A., Horie, K., Saita, Y., Iida, E., Honda, K., & Tsujimoto, G. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15263.x · Cited by 29
VACM-1 receptor is specifically expressed in rabbit vascular endothelium and renal collecting tubule
Burnatowska-Hledin, M. A., Lazdins, I. B., Listenberger, L. L., Zhao, P., Sharangpani, A., Folta, V., & Card, B. (1999) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1999.276.2.f199 · Cited by 29
Tsukaguchi, H., Matsubara, H., & Inada, M. (1995) · Kidney International · doi:10.1038/ki.1995.327 · Cited by 29
Zhang, S., Hirano, Y., & Hiraoka, M. (1995) · Circulation Research · doi:10.1161/01.res.76.4.592 · Cited by 29
Molecular cloning of two rat GRK6 splice variants
Firsov, D., & Elalouf, J. (1997) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1997.273.3.c953 · Cited by 28
Pena, A., Murat, B., Trueba, M., Ventura, M. A., Wo, N. C., Szeto, H. H., Cheng, L. L., Stoev, S., Guillon, G., & Manning, M. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm060928n · Cited by 27
Cho, H., Murakami, K., Nakanishi, H., Fujisawa, A., Isoshima, H., Niwa, M., Hayakawa, K., Hase, Y., Uchida, I., Watanabe, H., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030287l · Cited by 27
Attenuated stress-induced catecholamine release in mice lacking the vasopressin V1b receptor
Itoh, S., Yamada, S., Mori, T., Miwa, T., Tottori, K., Uwahodo, Y., Yamamura, Y., Fukuda, M., Yamamoto, K., Tanoue, A., et al. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00005.2006 · Cited by 33
Three Novel AVPR2 Mutations in Three Japanese Families with X-Linked Nephrogenic Diabetes Insipidus
Tajima, T., Nakae, J., Takekoshi, Y., Takahashi, Y., Yuri, K., Nagashima, T., & Fujieda, K. (1996) · Pediatric Research · doi:10.1203/00006450-199603000-00022 · Cited by 26
Mishima, K., Tsukikawa, H., Inada, K., Fujii, M., Iwasaki, K., Matsumoto, Y., Abe, K., Egawa, T., & Fujiwara, M. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01200-6 · Cited by 26
Yuasa, H., Ito, M. A., Oiso, Y., Kurokawa, M., Watanabe, T., Oda, Y., Ishizuka, T., Tani, N., Ito, S., & Shibata, A. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.2.361 · Cited by 26
Sun, S., Cao, H. W., Yao, N., Zhao, L., Zhu, X.-F., Ni, E., Zhu, Q., & Zhu, W. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0292-y · Cited by 29
Role of vasopressin in rat distal colon function
Cristià, E., Amat, C., Naftalin, R. J., & Moretó, M. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.118315 · Cited by 25
Lee, S., Choi, I. Y., Kang, S. S., & RIVIER, C. L. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1418.015 · Cited by 28
GRK2/β‐arrestin mediates arginine vasopressin‐induced cardiac fibroblast proliferation
Chen, Y., Xu, F., Zhang, L., Wang, X., Wang, Y., Woo, A. Y., & Zhu, W. (2016) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12696 · Cited by 26
Omura, T., Nabekura, J., & Akaike, N. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.32762 · Cited by 27
Bale, T. L. (1995) · Endocrinology · doi:10.1210/en.136.1.27 · Cited by 102
Yu, H., Wang, S., Teng, J.-L., Ji, X., Wu, Z., Ma, Q.-C., & Fu, X. (2012) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-012-0964-7 · Cited by 24
Vasopressin regulates the growth of the biliary epithelium in polycystic liver disease
Mancinelli, R., Franchitto, A., Glaser, S. S., Vetuschi, A., Venter, J. K., Sferra, R., Pannarale, L., Olivero, F., Carpino, G., Alpini, G. D., et al. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2016.93 · Cited by 27
Immunolocalization of V1 vasopressin receptors in the rat kidney using anti-receptor antibodies
González, C. B., Figueroa, C. D., Reyes, C. E., Caorsi, C. E., Troncoso, S., & Menzel, D. (1997) · Kidney International · doi:10.1038/ki.1997.445 · Cited by 24
Receptor‐Specific Antagonists of Vasopressin and Oxytocin
Manning, M., STOEV, S., Chan, W. Y., & Sawyer, W. H. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb55550.x · Cited by 24
René, P., Lenne, F., Ventura, M. A., BERTAGNA, X. Y., & de Keyzer, Y. (2000) · Gene · doi:10.1016/s0378-1119(99)00468-0 · Cited by 25
Vasopressin and oxytocin receptor mRNA expression during rat telencephalon development
Chen, Q., Schreiber, S. S., & Brinton, R. D. (2000) · Neuropeptides · doi:10.1054/npep.2000.0809 · Cited by 25
Xu, F., Sun, S., Wang, X., Ni, E., Zhao, L., & Zhu, W. (2017) · Molecular Pharmacology · doi:10.1124/mol.116.107698 · Cited by 23
Cellular Actions of Arginine Vasopressin in the Kidney.
Ishikawa, S. (1993) · Endocrine Journal · doi:10.1507/endocrj.40.373 · Cited by 23
Yarkov, A., Montero, S., Lemus, M., de Álvarez-Buylla, E. R., & Álvarez-Buylla, R. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02404-0 · Cited by 22
Lewis, S. J., Hoque, A., Walton, T. M., & Kooy, N. W. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.06.027 · Cited by 23
Properties of a new radioiodinated antagonist for human vasopressin V2 and V1a receptors
Ala, Y., Morin, D., Mahé, E., de la Cotte, N., Mouillac, B., Jard, S., Barberis, C., Tribollet, E., Dreifuss, J.-J., Sawyer, W. H., et al. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01021-2 · Cited by 23
Marcinkowski, W., Zhang, G., Smogorzewski, M. J., & Massry, S. G. (1997) · Kidney International · doi:10.1038/ki.1997.266 · Cited by 23
Jurzak, M., Fahrenholz, F., & Gerstberger, R. (1993) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1993.tb00517.x · Cited by 23
Kimura, T., & Ivell, R. (1999) · Results and problems in cell differentiation · doi:10.1007/978-3-540-49421-8_7 · Cited by 22
Hasunuma, I., Toyoda, F., Kadono, Y., Yamamoto, K., Namiki, H., & Kikuyama, S. (2010) · Cell and Tissue Research · doi:10.1007/s00441-010-1079-0 · Cited by 25
Effects of the renal medullary pH and ionic environment on vasopressin binding and signaling
Zalyapin, E. A., Bouley, R., Hasler, U., Vilardaga, J., Lin, H. Y.-F., Brown, D., & Ausiello, D. A. (2008) · Kidney International · doi:10.1038/ki.2008.412 · Cited by 22
A nonpeptide oxytocin receptor antagonist radioligand highly selective for human receptors
Lemaire, W., O’Brien, J. A., Burno, M., Chaudhary, A., Dean, D. C., Williams, P. D., Freidinger, R. M., Pettibone, D. J., & Williams, D. L. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02048-4 · Cited by 23
Expression of mRNAs Encoding Hormone Receptors in the Endolymphatic Sac of the Rat
Furuta, C. S. H. (1999) · Acta Oto-Laryngologica · doi:10.1080/00016489950181936 · Cited by 22
Sarmiento, J., Ehrenfeld, P., Añazco, C. C., Reyes, C. E., Troncoso, S., Figueroa, C. D., Meller-esterl, W., & Gonzelez, C. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00426.x · Cited by 22
Neuropeptide Receptors and Astrocytes
Krisch, B., & Mentlein, R. (1994) · International review of cytology · doi:10.1016/s0074-7696(08)62407-9 · Cited by 22
Impaired agonist-induced calcium signaling in hepatocytes from chronic renal failure rats
Massry, S. G., Klin, M., Ni, Z., Tian, J., Kedes, L., & Smogorzewski, M. J. (1995) · Kidney International · doi:10.1038/ki.1995.417 · Cited by 22
Yamamoto, K., Ikeda, U., Okada, K., Saito, T., & Shimada, K. (1997) · Hypertension Research · doi:10.1291/hypres.20.209 · Cited by 22
Oxytocin, vasopressin and their interplay with gonadal steroids
Dhakar, M. B., Stevenson, E. L., & Caldwell, H. K. (2013) · Oxytocin, Vasopressin and Related Peptides in the Regulation of Behavior · doi:10.1017/cbo9781139017855.003 · Cited by 20
“ADPKD-omics”: determinants of cyclic AMP levels in renal epithelial cells
Mehta, Y., Lewis, S. A., Leo, K. T., Chen, L., Park, E., Raghuram, V., Chou, C., Yang, C., Kikuchi, H., Khundmiri, S. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.10.014 · Cited by 21
Cenksoy, C., Özcan, P., Erdem, Ö., Sancak, B., & Gursoy, R. (2013) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2013.12.001 · Cited by 20
Campos, L. A., Couto, A. S., Iliescu, R., Santos, J. A., Santos, R. A. S., Ganten, D., Campagnole‐Santos, M. J., Bäder, M., & Baltatu, O. C. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.02.001 · Cited by 21
Gene Regulation System of Vasopressin and Corticotoropin-Releasing Hormone
Yoshida, M. (2008) · Gene Regulation and Systems Biology · doi:10.4137/grsb.s424 · Cited by 24
Peroxynitrite Elicits Dysfunction of Stereoselective S-Nitrosocysteine Recognition Sites
Lewis, S. J., Graves, J. E., Bates, J. N., & Kooy, N. W. (2005) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000181717.87204.2f · Cited by 20
Disorders of the Posterior Pituitary
Srivatsa, A., & Majzoub, J. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00012-9 · Cited by 23
Small interfering RNA-mediated functional silencing of vasopressin V2receptors in the mouse kidney
Hassan, A. H., Tian, Y., Zheng, W., Ji, H., Sandberg, K. L., & Verbalis, J. G. (2005) · Physiological Genomics · doi:10.1152/physiolgenomics.00147.2004 · Cited by 20
Renal and Central Vasopressin Receptors: Immunocytochemical Localization
Fahrenholz, F., Jurzak, M., Gerstberger, R., & Haase, W. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb55548.x · Cited by 20
The Cell Biology of Vasopressin Action
Brown, D., & Fenton, R. A. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10011-9 · Cited by 21
Over-expression of V1A receptors in PVN modulates autonomic cardiovascular control
Lozić, M., Tasić, T., Martin, A., Greenwood, M. P., Šarenac, O., Hindmarch, C. C. T., Paton, J. F. R., Murphy, D., & Japundžić‐Žigon, N. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.10.024 · Cited by 21
Expression of mRNA encoding vasopressin V1a, vasopressin V2, and ANP-B receptors in the rat cochlea
Furuta, H., Luo, L., Ryan, A. F., & Mori, N. (1998) · Hearing Research · doi:10.1016/s0378-5955(98)00009-4 · Cited by 18
Arpin‐Bott, M., Waltisperger, E., Freund‐Mercier, M. J., & Stoeckel, M. E. (1999) · The Nephron journals/Nephron journals · doi:10.1159/000045476 · Cited by 19
Nakayama, Y., Takano, Y., Eguchi, K., Migita, K., Saito, R., Tsujimoto, G., & Kamiya, H. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00274-7 · Cited by 20
Yamazaki, R. S., Chen, Q., Schreiber, S. S., & Brinton, R. D. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00285-9 · Cited by 19
Synergistic stimulation of DNA synthesis by bradykinin and vasopressin in swiss 3T3 cells
Kiehne, K., & Rozengurt, E. (1994) · Journal of Cellular Physiology · doi:10.1002/jcp.1041600313 · Cited by 19
Rawat, A., Chaube, R., & Joy, K. P. (2015) · Fish Physiology and Biochemistry · doi:10.1007/s10695-015-0026-0 · Cited by 21
Diabètes insipides néphrogéniques
Bichet, D. G. (2006) · Néphrologie & Thérapeutique · doi:10.1016/j.nephro.2006.07.010 · Cited by 22
V1a vasopressin receptor expression is modulated during myogenic differentiation
Alvisi, M., Arcangelis, V. D., Ciccone, L., Palombi, V., Alessandrini, M., Némoz, G., Molinaro, M., Adamo, S., & Naro, F. (2007) · Differentiation · doi:10.1111/j.1432-0436.2007.00231.x · Cited by 18
Vasopressin and sensory circumventricular organs
Jurzak, M., & SCHMID, H. A. (1999) · Progress in brain research · doi:10.1016/s0079-6123(08)61572-1 · Cited by 20
Anomalous antidiuretic activity of antidiuretic hormone antagonists
Kinter, L. B., Caltabiano, S., & Huffman, W. F. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90427-x · Cited by 18
Patchev, V. K., & Almeida, O. F. X. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb01153.x · Cited by 18
Knepper, M. A., Valtin, H., & Sands, J. M. (2000) · Comprehensive physiology · doi:10.1002/cphy.cp070313 · Cited by 17
The thymic education of developing T cells in self neuroendocrine principles
Geenen, V. G., Robert, F., Martens, H., Groote, D. D., & Franchimont, P. (1992) · Journal of Endocrinological Investigation · doi:10.1007/bf03344936 · Cited by 18
Inverse PCR-mediated cloning of the promoter for the rat vasopressin V2 receptor gene
Mandon‐Pepin, B., Bellanger, A.-C., & Elalouf, J. (1995) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00373834 · Cited by 19
The biochemical and physiological characteristics of receptors
Feener, E. P., & King, G. L. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00079-3 · Cited by 17
Arginine vasopressin regulates CFTR and ClC-2 mRNA expression in rat kidney cortex and medulla
Morales, M. M., Nascimento, D., Capella, M. A. M., Lopes, A. G., & Guggino, W. B. (2001) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240100671 · Cited by 17
Ancellin, N., Preisser, L., Corman, B., & Morel, A. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00914-9 · Cited by 17
Self-citationStoev, S., Cheng, L., Olma, A., Kliś, W. A., Manning, M., Sawyer, W. H., Wo, N. C., & Chan, W. Y. (1999) · Journal of Peptide Science · doi:10.1002/(sici)1099-1387(199903)5:3<141::aid-psc180>3.0.co;2-6 · Cited by 19
González, C. B., Herrera, V. L. M., & Ruiz‐Opazo, N. (1997) · Hypertension · doi:10.1161/01.hyp.29.4.957 · Cited by 17
Searcy, B. T., Bradford, C. S., Thompson, R. R., Filtz, T. M., & Moore, F. L. (2010) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2010.09.017 · Cited by 16
Arpin‐Bott, M., Kaissling, B., Waltisperger, E., Rabhi, M., Saussine, P., Freund‐Mercier, M. J., & Stoeckel, M. E. (2002) · Nephron Experimental Nephrology · doi:10.1159/000058346 · Cited by 16
Homologous and Heterologous Acute Desensitization of Vasopressin V1a Receptor in Xenopus Oocytes
Ancellin, N., & Morel, A. (1998) · Cellular Signalling · doi:10.1016/s0898-6568(97)00124-1 · Cited by 16
Self-citationThe Analysis of Ligand-Receptor Interactions in Platelet Activation
Kroll, M. H., & Schafer, A. I. (1995) · Elsevier eBooks · doi:10.1016/b978-012390120-0/50005-8 · Cited by 22
Lind, C. M., Birky, N. K., Porth, A. M., & Farrell, T. M. (2017) · Biology Open · doi:10.1242/bio.022616 · Cited by 16
Terashima, Y., Kondo, K., & Oiso, Y. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00078-8 · Cited by 15
Metadata
- Authors
- Morel, A., O'Carroll, A.-M., Brownstein, M. J., & Lolaft, S. J.
- Affiliations
- National Institutes of Health (US)
- ORCID
- Morel, Alain
- Venue
- Nature
- Published
- 1992-04
- Volume
- 356
- Issue
- 6369
- Pages
- 523-526
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2007060613
- Semantic Scholar
- e3358299b468c8f7ee7c12e49293b5113bd0ce45
- Cited by
- 477
- References
- 29
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 1 · 2023: 4 · 2022: 7 · 2021: 7 · 2020: 1 · 2019: 7 · 2018: 4 · 2017: 3 · 2016: 9 · 2015: 4 · 2014: 7 · 2013: 11 · 2012: 9
- FWCI
- 80.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- arginine vasopressin receptor, V1a receptor, G protein-coupled receptors, cDNA cloning, rats, receptor structure, transmembrane domain, ligand binding affinity, mRNA distribution, liver glycogenolysis, diuresis
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Cell Line, Cloning, Molecular, Dose-Response Relationship, Drug, Female, Cricetinae, Kidney, Liver, Molecular Sequence Data, Ovary, Receptors, Angiotensin, Recombinant Proteins, RNA, Messenger, Sequence Homology, Nucleic Acid, Spleen, Xenopus, Blotting, Northern, Gene Library, Receptors, Vasopressin, GTP-Binding Proteins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.